Elsebeth Staun-Ram

1.5k total citations
22 papers, 1.2k citations indexed

About

Elsebeth Staun-Ram is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Elsebeth Staun-Ram has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Elsebeth Staun-Ram's work include Multiple Sclerosis Research Studies (11 papers), Pregnancy and preeclampsia studies (4 papers) and Immune Response and Inflammation (3 papers). Elsebeth Staun-Ram is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Pregnancy and preeclampsia studies (4 papers) and Immune Response and Inflammation (3 papers). Elsebeth Staun-Ram collaborates with scholars based in Israel, France and Czechia. Elsebeth Staun-Ram's co-authors include Eliezer Shalev, Ariel Miller, Shlomit Goldman, Daniel Golan, Sara Dishon, Idit Lavi, Mira Barak, Sophia Ish‐Shalom, Lea Glass‐Marmor and Orit Rozenberg and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Elsebeth Staun-Ram

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsebeth Staun-Ram Israel 16 553 352 288 264 144 22 1.2k
Güven Lüleci Türkiye 21 134 0.2× 72 0.2× 750 2.6× 90 0.3× 286 2.0× 110 1.7k
P Cortinovis-Tourniaire France 5 874 1.6× 80 0.2× 104 0.4× 909 3.4× 96 0.7× 5 1.5k
Elena Dal Cin Italy 14 791 1.4× 62 0.2× 275 1.0× 293 1.1× 36 0.3× 16 1.4k
P Anastasiadis Greece 14 109 0.2× 303 0.9× 156 0.5× 59 0.2× 59 0.4× 67 722
Claudia A. Krusche Germany 17 216 0.4× 111 0.3× 353 1.2× 28 0.1× 39 0.3× 35 973
Alexandra Gellhaus Germany 25 348 0.6× 740 2.1× 695 2.4× 33 0.1× 503 3.5× 89 1.6k
Ping Cannon Australia 22 679 1.2× 926 2.6× 374 1.3× 22 0.1× 658 4.6× 72 1.8k
Haruki Nishizawa Japan 17 222 0.4× 514 1.5× 245 0.9× 18 0.1× 420 2.9× 50 964
Shiliang Shen United States 14 160 0.3× 154 0.4× 483 1.7× 46 0.2× 19 0.1× 23 1.3k
Marita Lipsanen‐Nyman Finland 23 176 0.3× 42 0.1× 755 2.6× 62 0.2× 337 2.3× 46 1.4k

Countries citing papers authored by Elsebeth Staun-Ram

Since Specialization
Citations

This map shows the geographic impact of Elsebeth Staun-Ram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsebeth Staun-Ram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsebeth Staun-Ram more than expected).

Fields of papers citing papers by Elsebeth Staun-Ram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsebeth Staun-Ram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsebeth Staun-Ram. The network helps show where Elsebeth Staun-Ram may publish in the future.

Co-authorship network of co-authors of Elsebeth Staun-Ram

This figure shows the co-authorship network connecting the top 25 collaborators of Elsebeth Staun-Ram. A scholar is included among the top collaborators of Elsebeth Staun-Ram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsebeth Staun-Ram. Elsebeth Staun-Ram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staun-Ram, Elsebeth, et al.. (2025). Immunotherapy-mediated modulation of the gut microbiota in multiple sclerosis and associations with diet and clinical response—the effect of dimethyl fumarate therapy. Therapeutic Advances in Neurological Disorders. 18. 4233587653–4233587653. 1 indexed citations
2.
Staun-Ram, Elsebeth, et al.. (2023). Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet. International Journal of Molecular Sciences. 24(19). 15024–15024. 9 indexed citations
3.
Milo, Ron, Elsebeth Staun-Ram, Dimitrios Karussis, et al.. (2022). Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses. Frontiers in Immunology. 13. 868915–868915. 26 indexed citations
4.
Staun-Ram, Elsebeth, et al.. (2022). The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis. Clinical Immunology. 238. 109017–109017. 2 indexed citations
5.
Staun-Ram, Elsebeth, et al.. (2020). Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS. Journal of Neuroimmunology. 343. 577230–577230. 13 indexed citations
6.
Staun-Ram, Elsebeth, et al.. (2019). HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(4). 2454302688–2454302688. 18 indexed citations
7.
Staun-Ram, Elsebeth, et al.. (2019). Fingolimod reduces CXCR4-mediated B cell migration and induces regulatory B cells-mediated anti-inflammatory immune repertoire. Multiple Sclerosis and Related Disorders. 34. 29–37. 24 indexed citations
8.
Avidan, Nili, Frédérique Truffault, Elsebeth Staun-Ram, et al.. (2017). Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. Journal of Autoimmunity. 82. 62–73. 21 indexed citations
9.
Staun-Ram, Elsebeth & Ariel Miller. (2017). Effector and regulatory B cells in Multiple Sclerosis. Clinical Immunology. 184. 11–25. 56 indexed citations
10.
Golan, Daniel, Elsebeth Staun-Ram, & Ariel Miller. (2016). Shifting paradigms in multiple sclerosis. Current Opinion in Neurology. 29(3). 354–361. 9 indexed citations
11.
12.
13.
Golan, Daniel, Elsebeth Staun-Ram, Lea Glass‐Marmor, et al.. (2013). The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behavior and Immunity. 32. 180–185. 55 indexed citations
14.
Avidan, Nili, et al.. (2013). Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells. PLoS ONE. 8(4). e62366–e62366. 28 indexed citations
15.
Toubi, Elias, Elsebeth Staun-Ram, Ayelet Snir, et al.. (2012). Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis. Journal of Neuroimmunology. 251(1-2). 45–54. 48 indexed citations
16.
Staun-Ram, Elsebeth & Ariel Miller. (2010). Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: Modulation by interferon-β and role played in cell migration. Journal of Neuroimmunology. 232(1-2). 200–206. 30 indexed citations
17.
Staun-Ram, Elsebeth, Shlomit Goldman, & Eliezer Shalev. (2009). Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion. Reproductive Biology and Endocrinology. 7(1). 135–135. 23 indexed citations
18.
Staun-Ram, Elsebeth, Shlomit Goldman, & Eliezer Shalev. (2009). p53 Mediates Epidermal Growth Factor (EGF) Induction of MMP-2 Transcription and Trophoblast Invasion. Placenta. 30(12). 1029–1036. 39 indexed citations
19.
Staun-Ram, Elsebeth & Eliezer Shalev. (2005). Human trophoblast function during the implantation process. Reproductive Biology and Endocrinology. 3(1). 56–56. 248 indexed citations
20.
Staun-Ram, Elsebeth, et al.. (2004). Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion.. Reproductive Biology and Endocrinology. 2(1). 59–59. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Güven Lüleci Breakdown of academic impact, for papers by P Cortinovis-Tourniaire Breakdown of academic impact, for papers by Elena Dal Cin Breakdown of academic impact, for papers by P Anastasiadis Breakdown of academic impact, for papers by Claudia A. Krusche Breakdown of academic impact, for papers by Alexandra Gellhaus Breakdown of academic impact, for papers by Ping Cannon Breakdown of academic impact, for papers by Haruki Nishizawa Breakdown of academic impact, for papers by Shiliang Shen Breakdown of academic impact, for papers by Marita Lipsanen‐Nyman
Rankless by CCL
2026